JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M203009200 on April 17, 2002

J. Biol. Chem., Vol. 277, Issue 25, 22573-22580, June 21, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22573    most recent
M203009200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakker, J.
Right arrow Articles by Nelson, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakker, J.
Right arrow Articles by Nelson, W. G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated pi -Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells*

Jila Bakker, Xiaohui Lin, and William G. NelsonDagger

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231-1000

During the pathogenesis of human hepatocellular carcinoma (HCC), the CpG island encompassing the pi -class glutathione S-transferase gene (GSTP1) becomes hypermethylated. Repression of transcription accompanying CpG island hypermethylation has been proposed to be mediated by methyl-CpG binding domain (MBD) proteins. We report here that inhibition of transcription from hypermethylated GSTP1 promoters in Hep3B HCC cells, which fail to express GSTP1 mRNA or GSTP1 polypeptides, appears to be mediated by MBD2. Treatment of Hep3B cells with 5-azadeoxycytidine (5-aza-dC), a methyltransferase inhibitor, activated GSTP1 expression, whereas treatment with trichostatin A, a histone deacetylase inhibitor, had little effect. To more precisely assess the contribution of the pattern of GSTP1 CpG island methylation on GSTP1 mRNA expression, Hep3B cells were treated for 72 h with 5-aza-dC and then subjected to limiting dilution cloning. Bisulfite sequencing was used to map the methylation patterns of the GSTP1 promoter region in GSTP1-expressing and -non-expressing clones. In the clone that expressed GSTP1 mRNA determined by Northern blot analysis and quantitative reverse transcriptase (RT)-PCR, widespread demethylation of at least one GSTP1 allele was evident. Chromatin immunoprecipitation experiments revealed the presence of MBD2, but not Sp1, at the GSTP1 promoter in Hep3B cells. In contrast, Sp1 was detected at the GSTP1 promoter in a GSTP1-expressing Hep3B 5-aza-dC subclone. To test whether MBD2 might be responsible for the inhibition of GSTP1 transcription from hypermethylated GSTP1 promoters, siRNAs were used to reduce MBD2 polypeptide levels in Hep3B cells. SssI-catalyzed methylation of GSTP1 promoter sequences resulted in diminished luciferase reporter activity after transfection into Hep3B cells. However, when hypermethylated GSTP1 promoter sequences were transfected into Hep3B cells that had been treated with siRNA-targeting MBD2 mRNA, no repression of luciferase reporter expression was evident. These findings implicate MBD2 in the repression of GSTP1 expression associated with GSTP1 CpG island hypermethylation in HCC cells.

* This work was supported by NCI, National Institutes of Health Grant CA 70196.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Rm. 151, Bunting-Blaustein Cancer Research Bldg., 1650 Orleans St., Baltimore, MD 21231-1000. Tel.: 410-614-1661; Fax: 410-502-9817; E-mail: bnelson@jhmi.edu.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
E. C. Lopes, E. Valls, M. E. Figueroa, A. Mazur, F.-G. Meng, G. Chiosis, P. W. Laird, N. Schreiber-Agus, J. M. Greally, E. Prokhortchouk, et al.
Kaiso Contributes to DNA Methylation-Dependent Silencing of Tumor Suppressor Genes in Colon Cancer Cell Lines
Cancer Res., September 15, 2008; 68(18): 7258 - 7263.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Bastian, G. S. Palapattu, S. Yegnasubramanian, X. Lin, C. G. Rogers, L. A. Mangold, B. Trock, M. Eisenberger, A. W. Partin, and W. G. Nelson
Prognostic Value of Preoperative Serum Cell-Free Circulating DNA in Men with Prostate Cancer Undergoing Radical Prostatectomy
Clin. Cancer Res., September 15, 2007; 13(18): 5361 - 5367.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
A. H. Ting, K. M. McGarvey, and S. B. Baylin
The cancer epigenome--components and functional correlates
Genes & Dev., December 1, 2006; 20(23): 3215 - 3231.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Lopez-Serra, E. Ballestar, M. F. Fraga, M. Alaminos, F. Setien, and M. Esteller
A Profile of Methyl-CpG Binding Domain Protein Occupancy of Hypermethylated Promoter CpG Islands of Tumor Suppressor Genes in Human Cancer.
Cancer Res., September 1, 2006; 66(17): 8342 - 8346.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Motomura, S. Senju, T. Nakatsura, H. Matsuyoshi, S. Hirata, M. Monji, H. Komori, D. Fukuma, H. Baba, and Y. Nishimura
Embryonic Stem Cell-Derived Dendritic Cells Expressing Glypican-3, a Recently Identified Oncofetal Antigen, Induce Protective Immunity against Highly Metastatic Mouse Melanoma, B16-F10
Cancer Res., February 15, 2006; 66(4): 2414 - 2422.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
S. Yegnasubramanian, X. Lin, M. C. Haffner, A. M. DeMarzo, and W. G. Nelson
Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation
Nucleic Acids Res., February 9, 2006; 34(3): e19 - e19.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. Sharma, J. Blum, X. Yang, N. Beaulieu, A. R. Macleod, and N. E. Davidson
Release of Methyl CpG Binding Proteins and Histone Deacetylase 1 from the Estrogen Receptor {alpha} (ER) Promoter upon Reactivation in ER-Negative Human Breast Cancer Cells
Mol. Endocrinol., July 1, 2005; 19(7): 1740 - 1751.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Bastian, G. S. Palapattu, X. Lin, S. Yegnasubramanian, L. A. Mangold, B. Trock, M. A. Eisenberger, A. W. Partin, and W. G. Nelson
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy
Clin. Cancer Res., June 1, 2005; 11(11): 4037 - 4043.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
S. M. Yiu, P. W. H. Wong, T.W. Lam, Y.C. Mui, H. F. Kung, M. Lin, and Y. T. Cheung
Filtering of Ineffective siRNAs and Improved siRNA Design Tool
Bioinformatics, January 15, 2005; 21(2): 144 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Stirzaker, J. Z. Song, B. Davidson, and S. J. Clark
Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells
Cancer Res., June 1, 2004; 64(11): 3871 - 3877.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Matarazzo and G. V. Ronnett
Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency
PNAS, May 18, 2004; 101(20): 7763 - 7768.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Sekimata and Y. Homma
Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF
Nucleic Acids Res., January 29, 2004; 32(2): 590 - 597.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. F. Fraga, E. Ballestar, G. Montoya, P. Taysavang, P. A. Wade, and M. Esteller
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties
Nucleic Acids Res., March 15, 2003; 31(6): 1765 - 1774.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.